首页 › 基金 › Aldebaran Capital, LLC › ANTX
Aldebaran Capital, LLC 对 ANTX 的持仓历史
AN2 THERAPEUTICS INC · 医疗保健
Aldebaran Capital, LLC 在 Q3 2026 的 13F 申报中披露持有 ANTX(AN2 THERAPEUTICS INC)367,706 股,市值约 US$2.0M,约占其申报组合的 1.41%,在其申报持仓中市值排名第 22 位。 Aldebaran Capital, LLC 最近 9 个申报季度中有 9 个季度披露了 ANTX 持仓,最早可追溯至 Q3 2024。
最后更新: 2026-11-13 · 来源: SEC EDGAR Form 13F-HR
Aldebaran Capital, LLC 对 ANTX 的持仓演变
Aldebaran Capital, LLC 于 Q3 2024 首次披露 ANTX 持仓:100,500 股(约 US$108K)。 该持仓在 Q3 2026 达到峰值 367,706 股,市值约 US$2.0M。 在 9 次申报中,Aldebaran Capital, LLC 2 次增持、5 次减持、1 次保持不变。 最近一期申报(Q3 2026)显示持股 367,706 股、市值约 US$2.0M。 持仓曾出现大幅变动:Q4 2024 增持约 242% (随后一个季度股价下跌 1%)。
逐季持仓明细
| 季度 | 股数 | 金额 | 变化 |
|---|---|---|---|
| Q3 2024 | 100.50K | $107.53K | 新进 |
| Q4 2024 | 343.68K | $474.28K | 增持 |
| Q1 2025 | 406.62K | $553.01K | 增持 |
| Q2 2025 | 402.75K | $426.92K | 减持 |
| Q3 2025 | 392.75K | $498.80K | 减持 |
| Q4 2025 | 376.77K | $429.52K | 减持 |
| Q1 2026 | 371.77K | $1.27M | 减持 |
| Q2 2026 | 367.44K | $1.78M | 减持 |
| Q3 2026 | 367.71K | $1.96M | 持有 |
折线上的点按变动类型着色;缺失季度表示该季未申报持仓。
关于 ANTX 与 13F 数据
ANTX(AN2 THERAPEUTICS INC)属于医疗保健行业。我们追踪的基金中还有 44 只申报持有 ANTX,申报仓位最大的包括:Vivo Capital, LLC (US$16.8M), Commodore Capital LP (US$14.2M), Spruce Street Capital LP (US$8.0M)。 根据美国 SEC 规定,管理资产超过 1 亿美元的机构投资者须在每季度结束后 45 天内提交 13F 表,披露其美股多头持仓。该数据不包含空头、大部分期权及海外持仓,因此应将其视为季度快照而非实时仓位。
其它持有 ANTX 的基金
- Vivo Capital, LLC 3.15M 股 · $16.78M · Q3 2026
- Commodore Capital LP 2.93M 股 · $14.20M · Q2 2026
- Spruce Street Capital LP 1.66M 股 · $8.04M · Q2 2026
- Almitas Capital LLC 1.47M 股 · $7.11M · Q2 2026
- Boxer Capital Management, LLC 749.03K 股 · $3.63M · Q2 2026
- Stonepine Capital Management, LLC 551.69K 股 · $2.67M · Q2 2026
- Sio Capital Management, LLC 529.93K 股 · $2.56M · Q2 2026
- Ally Bridge Group (NY) LLC 526.32K 股 · $2.55M · Q2 2026
- Prosight Management, LP 474.64K 股 · $2.30M · Q2 2026
- Velan Capital Investment Management LP 40.00K 股 · $193.60K · Q2 2026
更多关于 Aldebaran Capital, LLC
常见问题
How long has Aldebaran Capital, LLC held ANTX?
Aldebaran Capital, LLC has disclosed ANTX holdings in 9 of the last 9 reported quarters, going back to Q3 2024.
What is Aldebaran Capital, LLC's current position in ANTX?
As of Q3 2026, Aldebaran Capital, LLC holds 367.71K shares of ANTX (AN2 THERAPEUTICS INC), valued at $1.96M, representing 1.41% of its reported portfolio and ranking #22.
Has Aldebaran Capital, LLC been buying or selling ANTX?
In the latest 13F filing (Q3 2026), Aldebaran Capital, LLC held unchanged its position in ANTX. The position peaked in Q3 2026 at 367.71K shares.
Which other funds hold ANTX?
Other major institutional holders of ANTX include Vivo Capital, LLC, Commodore Capital LP, Spruce Street Capital LP, among 44 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.